Paul's RSS feed

Paul Handley

For Paul Handley's latest contributions to The Japan Times, see below:

/ Jun 15, 2013

Gene-patent case unlikely to harm biotech: experts

The U.S. Supreme Court’s rejection Thursday of natural DNA patent protection could hurt biotech companies, but specialists said it left enough safeguards for the industry to keep innovating. The court ruled that Myriad Genetics Inc., which sells expensive tests for the genetic markers for ...